A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.
Bey, P
A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Sep 1996 - 378-83 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0941-4355
10.1007/BF01788845 doi
Adult
Aged
Analysis of Variance
Antiemetics--administration & dosage
Double-Blind Method
Female
Humans
Indoles--administration & dosage
Injections, Intravenous
Linear Models
Male
Middle Aged
Nausea--etiology
Neoplasms--pathology
Quinolizines--administration & dosage
Radiotherapy, High-Energy--adverse effects
Treatment Outcome
Vomiting--etiology
A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Sep 1996 - 378-83 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0941-4355
10.1007/BF01788845 doi
Adult
Aged
Analysis of Variance
Antiemetics--administration & dosage
Double-Blind Method
Female
Humans
Indoles--administration & dosage
Injections, Intravenous
Linear Models
Male
Middle Aged
Nausea--etiology
Neoplasms--pathology
Quinolizines--administration & dosage
Radiotherapy, High-Energy--adverse effects
Treatment Outcome
Vomiting--etiology